The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.
The grant program focuses on supporting research related to human leukocyte antigen (HLA) and killer cell immunoglobulin-like receptor (KIR) genetic regions. It aims to define associations between variations in these regions and immune-mediated diseases, elucidate mechanisms underlying these associations, and validate association data to enhance the predictive power of clinical disease screening. This research is intended to advance therapeutic opportunities for immune-mediated diseases.